Guard against ovarian woes When Australian researchers recently
compared women with ovarian cancer to cancer - free women, they found that roughly one glass of wine a day seemed to reduce the risk of the disease by as much as 50 percent.
Not exact matches
The study, which
compared each model's success in Caucasian
women with those of Asian descent (Chinese, Japanese, Filipino, Korean and Vietnamese), also raised important questions about the effect of race on
cancer development: When Caucasian and Asian patients
with similar family histories of breast and
ovarian cancer were
compared, the Asian
women had higher rates of genetic mutation, although the rates of these
cancers for Asians have traditionally been lower.
Up to half of
women with advanced - stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist at Women's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian ca
women with advanced - stage
ovarian cancer might be cured,
compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist at
Women's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian ca
Women's College Research Institute, who calls for a new standard of treatment for
women with late - stage ovarian ca
women with late - stage
ovarian cancer.
The period of time before
ovarian cancer recurred (called progression - free survival) improved by nearly 3.5 months
with the additional drug (13.8 months
compared with 10.4 months for the
woman on chemotherapy alone).
Women with endometriosis have a 1.5 percent lifetime chance of developing
ovarian cancer compared with 1 percent in the general female population.
Women who took anastrozole experienced fewer womb and
ovarian cancers and non melanoma skin
cancers, and fewer deep vein thromboses and gynecological issues,
compared with those who took tamoxifen.
The researchers
compared the genes of more than 8,000 white European
women — including around 3,250
women diagnosed
with ovarian cancer, 3,400
women who did not have
cancer and 2,000
women who had a family history of the disease.
«
Women with a BRCA mutation have a 40 to 50 percent chance of getting
ovarian cancer in their lifetime
compared to somebody
with an average risk, who has a 1.8 percent lifetime risk,» she said.
In the early 80s, Harvard professor Dr. Daniel W. Cramer led a study
comparing 215 healthy
women with 215
women who had
ovarian cancer.